Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Fructose malabsorption syndrome

Putkonen L, Yao CK, Gibson PR

(2013), Curr Opin Clin Nutr Metab Care, 16(4), 473-7

Short-chain carbohydrates and functional gastrointestinal disorders

Shepherd SJ, Lomer MC, Gibson PR

(2013), Am J Gastroenterol, 108(5), 707-17

Design of clinical trials evaluating dietary interventions in patients with functional gastrointestinal disorders

Yao CK, Gibson PR, Shepherd SJ

(2013), Am J Gastroenterol, 108(5), 748-58

Inflammatory bowel disease: the GP’s role in shared care of patients

Christensen B, Headon B, Gibson PR

(2013), Med Today, 14(5), 16-28

Alternative investigations for irritable bowel syndrome

Philpott H, Nandurkar S, Lubel J, Gibson PR

(2013), J Gastroenterol Hepatol, 28(1), 73-7

Tranexamic acid without prophylactic factor replacement for prevention of bleeding in hereditary bleeding disorder patients undergoing endoscopy: a pilot study

Davis A, Walsh M, McCarthy P, Brown G, Roberts S, Tran H, Street A, Fong CY, Kemp W

(2013), Haemophilia, 19(4), 583-9

Prevalence of transfusion-acquired hepatitis C in an Australian bleeding disorder population

Northcott MJ, Ong WL, Walsh M, McCarthy P, Belleli D, Tran H, Street A, Kemp W, Davis AK

(2013), Haemophilia, 19(6), 847-52

Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience and review of safety and outcomes

Cheung W, Kavnoudias H, Roberts S, Szkandera B, Kemp W, Thomson KR

(2013), Technol Cancer Res Treat, 12(3), 233-41

Improved survival trend of patients with hepatocellular carcinoma at an Australian tertiary hospital between 1995-2009

Wong N, Haydon A, Kemp W, Wijeratne P, Roberts S

(2013), Intern Med J, 43(2), 197-203

Biologic therapy of Crohn’s disease: natalizumab, vedolizumab, CCX282-B

Chung A, Gibson PR

(2012), In: Baumgart DC (ed) Crohn’s Disease and Ulcerative Colitis. Springer, New York, Chapter 35, 441-52

SINGLE-01: a randomized, controlled trial comparing the efficacy and depth of insertion of single- and double-balloon enteroscopy by using a novel method to determine insertion depth

Efthymiou M, Desmond PV, Brown G, La Nauze R, Kaffes A, Chua TJ, Taylor AC

(2012), Gastrointest Endosc, 76(5), 972-80

Dietary management of infantile colic: a systematic review

Iacovou M, Ralston RA, Muir J, Walker KZ, Truby H

(2012), Matern Child Health J, 16(6), 1319-31

Systemic mastocytosis: a gastroenterologists perspective

Philpott H, Crowley P, Gow P, Douglass J, Nandurkar S, Gibson P

(2012), Frontline Gastroenterol, 3, 5-9

Effects of methylnaltrexone in patients with narcotic bowel syndrome: a pilot observational study

Gibson PR, Morrison G

(2012), Intern Med J, 42(8), 907-12

New treatments for hepatitis C: the protease inhibitors

Kitson MT, Roberts SK

(2012), Med Today, 13(11), 73-75

D-livering the message: the importance of vitamin D status in chronic liver disease

Kitson MT, Roberts SK

(2012), J Hepatol, 57(4), 897-909

Feasibility and performance of the FibroScan XL probe

Kemp W, Roberts S

(2012), Hepatology, 55(4), 1308-9

Safety of peginterferon alfa-2a plus ribavirin in a large multinational cohort of chronic hepatitis C patients

Lee SS, Roberts SK, Berak H, Dusheiko GM, Harley HA, Gane EJ, Husa P, Horsmans YJ, Hadziyannis SJ, Jenny Heathcote E, Messinger D, Tatsch F, Han KH, Ferenci P

(2012), Liver Int, 32(8), 1270-7

Early on-treatment viral load and baseline METAVIR score: improved prediction of sustained virological response in HCV genotype 1 patients

Crawford DH, Dore GJ, Sievert W, Cheng WS, Weltman M, McCaughan G, Rawlinson W, Marks PS, Yoshihara M, Rizkalla B, Roberts SK; CHARIOT Study Group

(2012), Antivir Ther, 17(5), 849-54

Safety profile of standard- vs. high-dose peginterferon alfa-2a plus standard-dose ribavirin in HCV genotype 1/4 patients: pooled analysis from 5 randomized studies

Marcellin P, Roberts SK, Reddy KR, Harrison SA, Jensen DM, Hadziyannis S, Diago M, Weltman M, Messinger D, Tatsch F, Rizzetto M

(2012), Expert Opin Drug Saf, 11(6), 901-9

20 21 22 23 24